Nov. 13, 2014, 4:28 PM
- CollabRx (NASDAQ:CLRX): FQ2 EPS of -$0.35
- Revenue of $176K (-29.9% Y/Y).
Aug. 19, 2014, 5:06 PM| Aug. 19, 2014, 5:06 PM
Aug. 14, 2014, 4:28 PM
- CollabRx (NASDAQ:CLRX): FQ1 EPS of -$0.61.
- Revenue of $64K.
Feb. 11, 2014, 5:10 PM
- CollabRx (CLRX): Q4 EPS of -$0.52.
- Revenue of $56K.
CollabRx Inc is a data analytics company. It is engaged in developing and delivering knowledge-based products and services that informs healthcare decision-making, with an emphasis on genomics-based 'precision' medicine and big data analytics.
Industry: Application Software
Country: United States
Other News & PR